Association between BMI (body mass impact) and COVID-19
DOI:
https://doi.org/10.54097/hset.v14i.1832Keywords:
BMI, COVID-19, obesity, overweight, malnutritionAbstract
The 2019 novel the Corona Virus Disease 2019, known as COVID-19, has sickened more than 1 million people and killed nearly 600,000 in Wuhan, China. The binding of Angiotensin-converting enzyme 2 receptor binding causesSARS-CoV-2 to affect various organs. There is growing evidence linking severe COVID-19 to overweight, obesity and malnutrition (abnormal BMI). The aim of the study was to investigate the relationship between abnormal BMI and COVID-19 and determine the causes of negative outcomes.
Downloads
References
Benedetti F, Cmpisi G, et al.. Evolution patterns of SARS-CoV-2: snapshot on its genome variants. Biochem Biophys Res Commun 2021;538:88–91
Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27:325–8.
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061.
Tchang BG, Saunders KH, Igel LI. Best practices in the management of overweight and obesity. Med Clin North Am 2021;105:149–74.
Rashedi J, Mahdavi Poor B, Asgharzadeh V, et al. Risk factors for COVID-19[J]. Infez Med, 2020, 28(4): 469-474.
hu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.
de Lusignan S, Dorward J, Correa A, et al.. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect Dis 2020;20:1034–42.
Mandal, D. A. (2020, November 27). Body mass index and severe covid-19. News. Retrieved August 16, 2022, from
Nakeshbandi, M., Maini, R., Daniel, P. et al. The impact of obesity on COVID-19 complications: a retrospective cohort study. Int J Obes 44, 1832–1837 (2020). https://doi.org/10.1038/s41366-020-0648-x
Popkin BM, Du S, Green WD, et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev
Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. 2020; 21e1312
Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. 2020; 21e13128
Hilgenfeld R, Peiris M. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses. Antiviral Res. 2013;100(1):286-295.
Increased risk of influenza among vaccinated adults who are obese. Int J Obes (Lond). 2017; 41: 1324-1330
Louie JK, Acosta M, Samuel MC, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis. 2011;52(3):301-312.
[16]Hanckova M, Betakova T. Pandemics of the 21st century: the risk factor for obese people. Viruses 2021; 14: 25
Dagan N, Barda N, Kepten E. et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med 2021; 384: 1412-1423
Vabret N, Britton GJ, Gruber C, et al. Immunology of COVID-19: current state of the science. Immunity. 2020;52:910-941.
Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships:https://doi.org/10.1111/obr.13128
Zhou P, Yang X, Wang X, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 10.1038/s41586-020-2012-7
HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID‐19 . Mar 17, 2020. ACC News Story
Jia X, Yin C, Lu S, et al. Two things about COVID‐19 might need attention. Preprints. 2020;2020020315 10.20944/preprints202002.0315.v1
Pinheiro TA, Barcala‐Jorge AS, Andrade JMO, et al. Obesity and malnutrition similarly alter the renin‐angiotensin system and inflammation in mice and human adipose. J Nutr Biochem. 2017;48:74‐82.
Patel AB, Verma A. COVID‐19 and angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? JAMA. 2020. 10.1001/jama.2020.4812
Almond MH, Edwards MR, Barclay WS, et alObesity and susceptibility to severe outcomes following respiratory viral infectionThorax 2013;68:684-686.
Corne JM, Marshall C, Smith S, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002;359:831–4.
eran-Cabanillas E, Montalvo-Corral M, Caire-Juvera G, et al. Decreased interferon-α and interferon-β production in obesity and expression of suppressor of cytokine signaling. Nutrition 2013;29:207–12.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
